Clicky

IDT Australia Limited  (IDT)

Description: IDT Australia Limited is engaged in the supply of products and provision of research and development and other technical services for the pharmaceutical and allied industries. The Company's segments include CMAX, Boronia and Corporate/Unallocated. Its CMAX is a clinical trial facility in Adelaide, South Australia. It has an integrated manufacturing, development and corporate facility at Boronia, Victoria. The Company specializes in manufacture of active pharmaceutical ingredients (API) and finished dose products, including beta lactams; microbiological and analytical testing; clinical packaging, and Phase I and first time in man clinical trials research and pharmacy services. Its IDT Pharma specializes in the development, scale-up and current goods manufacturing practices (cGMP) clinical and commercial manufacture of cytotoxic API and finished drug product. The Company also offers a range of clinical trial labelling, packaging and dispensing services.


Keywords: Pharmaceutical Packaging Pharmacy Active Pharmaceutical Ingredients Clinical Trial Boron Companies Based In Ahmedabad Pharmacy Services Lactams Manufacturing Practice Integrated Manufacturing

Home Page: en.idtaus.com.au

IDT Technical Analysis

45 Wadhurst Drive
Boronia, VIC 3155
Australia
Phone: 61 3 9801 8888


Officers

Name Title
Mr. Paul McDonald Interim CEO
Mr. Chris Kagiaros Head of People & Culture
Dr. David Sparling BVSc (Hons), GDipAppCGov, L.L.B., LLB (Hons) Joint company Sec.
Mr. Vasanthakumar Mahendran Interim Chief Financial Officer
Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP Company Sec.

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.768
Price-to-Sales TTM: 1.5697
IPO Date:
Fiscal Year End: June
Full Time Employees: 0
Back to stocks